Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

21 Jan 2010 07:00

RNS Number : 8912F
ViaLogy PLC
21 January 2010
 



VIALOGY PLC

TRADING STATEMENT

 

PERMIAN BASIN WELL SUCCESS IS TECHNOLOGY MILESTONE

--- "A-Level" stress test for QuantumRD

--- Broad oil patch application seen for technology

London, January 21, 2010, ViaLogy PLC (LSE: VIY). ViaLogy announces that, under contract to its client Fasken Oil and Ranch, Ltd. of Midland, Texas, the first successful well has been drilled and is in the process of being completed on their Andrews County prospect. The leading privately-held Exploration and Production company agreed to collaborate with ViaLogy to use its proprietary technology, QuantumRD®, to analyze 3-D and multi-component seismic data, well logs and geological records to locate well sites in a 10 square mile Permian Basin acreage block. 

Drilling at the ViaLogy-designated location took three weeks and reached a prescribed total depth of 11,241 feet. Initial well log analysis shows potential for multiple zones that could be high-graded, highlighted by a net interval of over 50' feet of significant porosity in the Strawn formation alone. Strawn limestone porosities are typically very low. For this formation to be economically viable porosity must reach at least 4%. One of ViaLogy's key challenges was to locate this porosity and to quantify its aerial extent. Strawn targets are typically found at depths greater than 9000 feet and with 3% porosities or less are deemed non-productive. The QuantumRD technology succeeded in locating large continuous zones of 6% plus porosity, a major achievement. Detailed volumetrics will be computed in the near-term.

 

All the more significant is the fact that over the last 50 years only three of 18 attempted Strawn wells in the prospect area showed production. Of the 15 remaining, seven were completed to produce oil from shallower zones in the Wolfcamp formations, no porosity having been found in the Strawn. Eight were declared as dry holes. Additionally, preliminary work shows that the ViaLogy technology can increase the ability to detect hydrocarbon presence directly using seismic data to accurately characterize Wolfcamp carbonates.

 

Participating in the Fasken prospect analysis as an advisor is Dr. Bob Hardage of the University of Texas' Bureau of Economic Geology (UT BEG), widely acknowledged as one of America's leading technology centers for hydrocarbon exploration.

 

Reviewing the drilling results, Dr. Hardage commented, "The prediction of a higher porosity zone within the Strawn is impressive and appears to validate the advantages of the weak signal processing capability underlying QuantumRD to see subtle changes in the data. Porosity variations in Strawn stratigraphy are difficult to amplify using conventional geophysical processing." Despite advances in 3D seismic acquisition and processing, the exploration industry has faced a major challenge in characterizing porosity in complex stratigraphic formations known to exhibit fracture and structural changes below acquisition resolution.

 

According to the client firm's Chief Geophysicist, "We are impressed by the accuracy of ViaLogy's predictions, and especially pleased with QuantumRD's capability to use seismic data to accurately detect porosity zones within the Strawn formation. This was a very difficult problem. Significant undeveloped acreage still exists in the Midland Basin. The introduction of a technology that can characterize porosity in deeper carbonate intervals could make a substantial difference."

He added, "This well demonstrated to us QuantumRD's potential to determine drilling locations based on our exploration criteria. We look forward to working closely with ViaLogy to discover and develop deeper formations on our acreage including the Strawn, Devonian, and Ellenburger"

ViaLogy CEO Robert Dean said, "We couldn't be more pleased with our performance. The only real test for an oil-finding technology is: Can it find oil in the field - not in the laboratory? This is what we are focused on and we're looking forward to proving our technology in the field. Our core patented technology, a technique for the injection of noise to enhance the signal to noise ratios seen in seismic data, allows us to extract more information from the data - and to identify sub-surface characteristics more effectively than other techniques. This challenge was to locate oil and gas in formations that had often eluded other efforts and available techniques. This has been a great partnership that will allow us to enhance and improve the ability of E&P companies to produce from Wolfberry, Strawn and deeper formations."

ViaLogy PLC

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807) 

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756) 

Nominated Advisor to ViaLogy PLC (Seymour Pierce) 

Mark Percy +44 (0) 20-7107-8000 

About ViaLogy: Network Centric Signal Processing 

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results,

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUUUGUPUPPU
Date   Source Headline
15th May 20187:00 amRNSYear-end Trading Update and £2.5m Fundraising
30th Apr 20184:00 pmRNSNotice of Trading Update
29th Mar 20187:00 amRNSPremaitha to attend industry conferences in APAC
26th Mar 20187:00 amRNSUpdate on UK patent infringement claim
16th Feb 20187:00 amRNSPremaitha secures market entry into Egypt
14th Feb 201810:25 amRNSHolding(s) in Company
12th Feb 20187:00 amRNSThermo Fisher - issue of warrants
6th Feb 20187:00 amRNSPremaitha to attend key conferences in Middle East
5th Feb 20187:00 amRNSPremaitha's IONA test approved for sale in Brazil
24th Jan 20187:00 amRNSUK High Court grants right to appeal
22nd Jan 20187:00 amRNSSecured loan facility agreement with Thermo Fisher
29th Dec 20177:00 amRNSHalf Year Results
11th Dec 20177:00 amRNSPremaitha secures four further laboratories in EU
1st Dec 20179:40 amRNSPremaitha CEO Wins Outstanding Contribution Award
27th Nov 20177:00 amRNSMiddle East laboratory network expansion
23rd Nov 20177:00 amRNSPremaitha signs new partner in East Asia
21st Nov 201710:47 amRNSLitigation First Instance Judgment
30th Oct 201710:08 amRNSGrant of Share Options
24th Oct 20173:45 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Statement
13th Oct 20177:00 amRNSMiddle East Update
29th Sep 20177:04 amRNSFinal Results
29th Sep 20177:01 amRNSNotice of AGM
21st Sep 20174:05 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSPremaitha to offer NIPT in South Africa
7th Sep 20173:10 pmRNSFurther Patent Infringement Claims
29th Aug 20177:00 amRNSApproved for Good Manufacturing Process in Brazil
18th Jul 20172:02 pmRNSHolding(s) in Company
12th Jul 20177:00 amRNSInvestment Agreement Extension with Thermo Fisher
10th Jul 20177:00 amRNSPremaitha announces two laboratory hub contracts
3rd Jul 20177:00 amRNSLitigation Update
27th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSPremaitha launches Sage NIPT solution
5th Jun 20177:00 amRNSIndia Business Update
26th May 20177:00 amRNSIONA test validation on Thermo Fisher's Ion S5
19th May 20172:30 pmRNSPremaitha welcomes NIPT recommendation in France
16th May 20177:00 amRNSYear End Trading Update
12th May 20172:15 pmRNSUpdate Re. Swiss Customer
3rd Apr 20174:48 pmRNSHolding(s) in Company
31st Mar 20174:00 pmRNSSecond tranche of warrants issued to Thermo Fisher
17th Mar 20177:15 amRNSHardman Research: Expanding global distribution
13th Mar 20177:00 amRNSPremaitha to Attend International Medical Events
2nd Mar 201711:03 amRNSCompletion of Yourgene Acquisition
27th Feb 20177:00 amRNSCompletion of Acquisition
22nd Feb 20179:37 amRNSHolding(s) in Company
20th Feb 20177:00 amRNSMiddle East Business Update
16th Feb 20175:34 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSIssue of Equity
14th Feb 20179:32 amRNSHolding(s) in Company
13th Feb 20177:00 amRNSNew partnership with European diagnostics group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.